Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.35 USD
Change Today +0.01 / 2.94%
Volume 3.5K
CRXM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

taxus cardium pharmaceutical (CRXM) Snapshot

Open
$0.25
Previous Close
$0.34
Day High
$0.35
Day Low
$0.25
52 Week High
04/29/15 - $0.63
52 Week Low
02/13/15 - $0.07
Market Cap
4.5M
Average Volume 10 Days
4.7K
EPS TTM
$-0.29
Shares Outstanding
12.8M
EX-Date
10/24/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TAXUS CARDIUM PHARMACEUTICAL (CRXM)

Related News

No related news articles were found.

taxus cardium pharmaceutical (CRXM) Related Businessweek News

No Related Businessweek News Found

taxus cardium pharmaceutical (CRXM) Details

Taxus Cardium Pharmaceuticals Group Inc. operates as a regenerative medicine biotechnology company. The company focuses on developing regenerative therapeutics to promote the activation and growth of microvascular circulation to enhance perfusion of ischemic cardiac tissue as a potential treatment for heart disease; and granulation tissue as a treatment for chronic non-healing wounds. The company provides Excellagen, a topical gel for wound healing of diabetic foot ulcers and other dermal wounds, as well as serves as a biologics delivery platform. It also develops Generx, a Phase III clinical study product candidate for the treatment of patients with cardiac microvascular insufficiency due to advanced coronary artery disease. In addition, the company offers LifeAgain, a medical analytics and social media-driven enabled e-commerce platform that is focused on developing, marketing, and direct sale of life insurance programs and other insurance products. It has strategic collaborations with Shanxi Taxus Pharmaceuticals Co., Ltd. for the development of advanced regenerative medicine therapeutics products. The company was formerly known as Cardium Therapeutics, Inc. and changed its name to Taxus Cardium Pharmaceuticals Group, Inc. in March 2014. Taxus Cardium Pharmaceuticals Group, Inc. was founded in 2003 and is headquartered in San Diego, California.

3 Employees
Last Reported Date: 05/22/15
Founded in 2003

taxus cardium pharmaceutical (CRXM) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $207.8K
Chairman of Scientific Advisory Board and Chi...
Total Annual Compensation: $244.3K
Compensation as of Fiscal Year 2014.

taxus cardium pharmaceutical (CRXM) Key Developments

Taxus Cardium Pharmaceuticals Group Inc. announced delayed 10-Q filing

On 08/17/2015, Taxus Cardium Pharmaceuticals Group Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

TaxuCardium Pharmaceuticals Group Inc., Annual General Meeting, Jun 25, 2015

TaxuCardium Pharmaceuticals Group Inc., Annual General Meeting, Jun 25, 2015., at 09:00 Pacific Standard Time. Location: San Diego Marriott Del Mar. Agenda: To elect four Class III directors, each to serve until the next annual meeting of stockholders held to elect Class III directors and until their respective successor is elected and qualified; to ratify the selection of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2015; and to transact such other business as may properly come before the meeting or any adjournment or postponement thereof.

TaxuCardium Pharmaceuticals Group Inc. announced delayed 10-Q filing

On 05/18/2015, TaxuCardium Pharmaceuticals Group Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRXM:US $0.35 USD +0.01

CRXM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
MiMedx Group Inc $9.82 USD +0.15
View Industry Companies
 

Industry Analysis

CRXM

Industry Average

Valuation CRXM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAXUS CARDIUM PHARMACEUTICAL, please visit www.cardiumthx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.